Gene ontology analysis of pairwise genetic associations in two genome-wide studies of sporadic ALS

BioData Mining

Volumn 5, Issue 1, 2012, Pages

  Kim, Nora Chung ^a   Andrews, Peter C ^a   Asselbergs, Folkert W ^c   Frost, H Robert ^a   Williams, Scott M ^a   Harris, Brent T ^d   Read, Cynthia ^b   Askland, Kathleen D ^b   Moore, Jason H ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN FILAMENT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; MULTIFACTOR DIMENSIONALITY REDUCTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 84864184376     PISSN: None     EISSN: 17560381     Source Type: Journal    
DOI: 10.1186/1756-0381-5-9     Document Type: Article

References (21)

1. ALS Association, http://www.alsa.org/about-als/facts-you-should-know.html
2. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, et al. N Engl J Med 2007 357 8 775 788 10.1056/NEJMoa070174 17671248
3. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Schymick JC, Scholz SW, Fung HC, Britton A, Arepalli S, Gibbs JR, et al. Lancet Neurol 2007 6 4 322 328 10.1016/S1474-4422(07)70037-6 17362836
4. A genome-wide association study of sporadic ALS in a homogenous Irish population. Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, Greenway MJ, Bradley DG, Traynor BJ, Hardiman O, Hum Mol Genet 2008 17 5 768 774 18057069
5. Screening for replication of genome-wide SNP associations in sporadic ALS. Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O, Eur J Hum Genet 2009 17 2 213 218 10.1038/ejhg.2008.194 18987618
6. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, et al. Nat Genet 2009 41 10 1083 1087 10.1038/ng.442 19734901
7. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, Myllykangas L, et al. Lancet Neurol 2010 9 10 978 985 10.1016/S1474-4422(10)70184-8 20801718
8. Multifactor dimensionality reduction for graphics processing units enables genome-wide testing of epistasis in sporadic ALS. Greene CS, et al. Bioinformatics 2010 26 5 694 695 10.1093/bioinformatics/btq009 20081222
9. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH, Am J Hum Genet 2001 69 138 147 10.1086/321276 11404819
10. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Ritchie MD, Hahn LW, Moore JH, Genet Epidemiol 2003 24 150 157 10.1002/gepi.10218 12548676
11. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Hahn LW, Ritchie MD, Moore JH, Bioinformatics 2003 19 376 382 10.1093/bioinformatics/btf869 12584123
12. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, White BC, J Theor Biol 2006 241 252 261 10.1016/j.jtbi.2005.11.036 16457852
13. Pathway-based approaches for analysis of genomewide association studies. Wang K, Li M, Bucan M, Am J Hum Genet 2007 81 1278 1283 10.1086/522374 17966091
14. Layers of epistasis: genome-wide regulatory networks and network approaches to genome-wide association studies. Cowper-Sallari R, Cole MD, Karagas MR, Lupien M, Moore JH, Wiley Interdiscip Rev Syst Biol Med 2011 3 513 526 10.1002/wsbm.132 21197657
15. Exploratory visual analysis pharmacogenomic results. Reif, Pac Symp Biocomput 2005 296 307
16. Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Askland K, Read C, Moore JH, Hum Genet 2009 125 1 63 79 10.1007/s00439-008-0600-y 19052778
17. Ion channels and schizophrenia: a gene-set based analytic approach to GWAS data for biological hypothesis testing. Askland K, Read C, O'Connell JH, Moore C, Hum Genet 2012 131 3 373 391 10.1007/s00439-011-1082-x 21866342
18. Molecular signatures database (MSigDB) 3.0. Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Bioinformatics 2011 27 1739 1740 10.1093/bioinformatics/btr260 21546393
19. Neurodegeneration: diseases of the cytoskeleton? McMurray CT, Cell Death Differ 2000 7 10 861 865 10.1038/sj.cdd.4400764 11279530
20. Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease). Julien JP, Millecamps S, Kriz J, Novartis Found Symp 2005 264 183 192 15773754
21. International Multiple Sclerosis Genetics Consortium: A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Bush WS, McCauley JL, DeJager PL, Dudek SM, Hafler DA, Gibson RA, Matthews PM, Kappos L, Naegelin Y, Polman CH, Hauser SL, Oksenberg J, Haines JL, Ritchie MD, Genes Immun 2011 12 5 335 340 10.1038/gene.2011.3 21346779